sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

North America Intravenous Immunoglobulin Market Scope And Analysis

  • Report Code : TIPRE00030117
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 107
Buy Now

North America Intravenous Immunoglobulin Market Analysis, Trends, and Scope 2023 to 2030

Buy Now

North America Intravenous Immunoglobulin Market Report North America Intravenous Immunoglobulin Market Size and Share North America Intravenous Immunoglobulin Market Scope and Analysis

North America Intravenous Immunoglobulin Market Report Scope

Report Attribute Details
Market size in 2022 US$ 5,042.91 Million
Market Size by 2030 US$ 8,747.81 Million
Global CAGR (2022 - 2030) 7.1%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By Type
  • IgG
  • IgA
  • IgM
By Application
  • Immunodeficiency Diseases
  • Chronic Inflammatory Demyelinating Polyneuropathy
  • Idiopathic Thrombocytopenic Purpura
  • Multifocal Motor Neuropathy
  • Hypogammaglobulinemia
  • Guillain-Barre Syndrome
  • Specific Antibody Deficiency
  • Inflammatory Myopathies
  • Myasthenia Gravis
By Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
By End User
  • Hospitals
  • Specialty Clinics
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Market leaders and key company profiles
  • Takeda Pharmaceutical Co Ltd
  • Grifols SA
  • Pfizer Inc
  • ADMA Biologics Inc
  • Bio Products Laboratory Ltd
  • Octapharma AG
  • Kedrion SpA
  • CSL Ltd
  • LFB Group